From Dismissed Pain to Stage 4 Diagnosis: One Patient’s Journey Highlights the Invisible Battles of Rare Cancers

In observance of Rare Cancer Day, the National Organization for Rare Disorders (NORD) has shared the compelling and deeply personal account of Sarah S., a Maryland resident whose path to a stage 4 cancer diagnosis reveals the profound challenges, uncertainties, and systemic shortcomings faced by individuals living with rare and invisible diseases. Sarah’s story underscores the vital importance of medical advocacy, the harrowing reality of living with microscopic disease, and the urgent need for greater awareness and policy support surrounding rare and young adult cancers.

The Surgery That Changed Everything

For years, Sarah’s body was in a state of open rebellion. She navigated a daily landscape of extreme abdominal pain, debilitating stabbing cramps that routinely forced her to the floor, fainting spells, overwhelming fatigue, and an inability to properly digest food or eat normal meals. Within just a few months, she experienced an unexplained weight loss of forty pounds. Her menstrual cycles were excruciating, leading her to miss work, lose precious time with her family, and make countless emergency room visits.

Yet, for Sarah, the physical agony was matched by an emotional toll that cut just as deeply: the pervasive disbelief of medical professionals.

It was not until she consulted a female physician—someone who actively listened and validated her symptoms—that Sarah found a glimmer of hope. Following a careful and comprehensive evaluation, she was diagnosed with adenomyosis and endometriosis. For the first time, she felt that someone was taking her suffering seriously, paving the way for a hysterectomy scheduled for January 28, 2023. Going into the procedure, Sarah believed she was finally closing a long, painful chapter of her life, completely unaware that she was about to open an entirely new and unexpected one.

During the operation, her surgeon noticed abnormalities in the appearance of her appendix. While Sarah remained under general anesthesia, the surgeon contacted her husband, Andy, to request permission to remove the organ. Andy agreed without hesitation, a split-second decision that ultimately saved Sarah’s life.

A Diagnosis That Arrived Quietly

The revelation came through a digital notification on February 3, 2023, delivered via a MyChart message without prior warning or clinical preparation. Sarah was diagnosed with neuroendocrine cancer of the appendix.

No diagnostic scans had detected the malignancy beforehand. No routine blood tests had raised alarms, and standard pathology reports prior to surgery had given no indication that cancer was present. The malignancy was discovered entirely by chance because a skilled surgeon noticed visual anomalies during a completely unrelated procedure.

Choosing Hope Without Certainty: Sarah's Rare Cancer Story - National Organization for Rare Disorders

Just five days later, on February 8—the day before her thirty-eighth birthday—Sarah and Andy met with Dr. Armando Sardi, a recognized expert in rare abdominal cancers. Dr. Sardi delivered the devastating news that she had stage 4 disease and that there was no known cure. Sarah recalls feeling entirely stunned, as though the air had been pulled from the room, thrusting her from planning her post-hysterectomy recovery straight into confronting her own mortality in less than a week.

Dr. Sardi outlined a complex and intensive procedure known as CRS/HIPEC (Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy), designed to remove visible tumors and deliver heated chemotherapy directly into the abdominal cavity. While not a curative solution, the treatment offered a viable path to extending her life.

When Sarah expressed deep anxiety about having to cancel an upcoming family vacation, Dr. Sardi leaned across his desk, took her hands, and looked directly into her eyes. Telling her to go on the trip with her family and reminding her that she was not dying tomorrow, the specialist provided a moment of grounding humanity that reminded Sarah she was still very much alive.

Living with What Can’t Be Seen

Following their return home, Sarah’s surgery was scheduled for April 20, 2023. Dr. Sardi successfully removed all visible disease, excising everything that could be detected with the naked eye. Sarah woke up exhausted, sore, and profoundly grateful.

However, a complex reality persists. While earlier pathology did not show visible tumors on standard diagnostics, cancer cells were present at a microscopic level—far too small to be captured by imaging scans or blood tests. This microscopic presence remains the primary source of her ongoing anxiety.

Reflecting on her medical history, Sarah recalled that back in 2013, a surgeon had remarked that she must be "one tough cookie," theorizing at the time that she had likely suffered from appendicitis and simply fought through it. That surgeon left her appendix intact, completely unaware that cancer cells were already lurking undetected.

Today, when Sarah experiences frequent physical illness—enduring significant episodes up to fifteen to twenty times a day—she navigates a difficult psychological space. With no clear clinical signs of recurrence, she exists constantly between the reassurance that "nothing shows" on tests and the sobering knowledge that "nothing showed last time either." This uncertainty is heavy, but it has fundamentally transformed her perspective on resilience.

Redefining Strength

For a long time, Sarah equated strength with endurance—pushing through pain, ignoring physical distress, and proving she could handle any hardship. Cancer fundamentally shifted that definition. She learned that true strength means listening to the body when something feels fundamentally wrong, advocating for oneself in medical settings where symptoms are routinely dismissed, and allowing fear to exist without letting it steal the present moment.

Choosing Hope Without Certainty: Sarah's Rare Cancer Story - National Organization for Rare Disorders

The disease exacted a heavy toll on her professional identity. In 2004, Sarah joined the Air Force to earn funding through the GI Bill, where she met Andy and eventually went on to earn her master’s degree in 2016. She spent eight dedicated years teaching history, civics, geography, and language to children. Letting go of her career as a teacher was devastating, but the transition did not extinguish her commitment to public service.

Sarah continues to show up for others, sharing her hard-earned insights and supporting individuals navigating similar frightening paths, particularly those who feel dismissed or unseen by the medical establishment. She serves as an active volunteer with the Abdominal Cancers Alliance, working to raise awareness regarding rare and advanced malignancies.

Choosing Hope Without Certainty

Sarah does not live in denial; rather, she lives in a state of heightened awareness. She acknowledges that her cancer may never present itself clearly on a scan and that fear will likely remain a persistent companion. Yet, she maintains a firm belief in her own agency, choosing connection over isolation, presence over panic, and advocacy over silence.

Her message to newly diagnosed patients, individuals struggling with scan anxiety, or those carrying the burden of an unpredictable disease is clear: experiencing fear does not make someone weak, and needing reassurance is not a failure. Most importantly, she emphasizes that patients walking these lonely roads are not alone. Hope does not require absolute certainty; frequently, it is simply the daily choice to keep moving forward when the path ahead remains obscured.

Sarah’s journey began with ignored pain and an invisible cancer, but it continues through resilience, gratitude, and an unwavering commitment to ensuring that rare cancer patients are truly seen and believed.

In recognition of Rare Cancer Day, advocacy organizations like NORD continue to urge policy action, encouraging citizens to contact their senators in support of the Asal Sayas National Strategy on Young Adult Cancers Act, and inviting patients to share their own experiences to foster a broader understanding of rare malignancies nationwide.

Nana

Penulis aktif di HypePress yang membagikan konten inspiratif, informasi terkini, dan gaya hidup untuk generasi muda.

Artikel Bermanfaat dan Menghibur Lainnya